StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)

Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%

Pfizer Acquisition Contingent Consideration Liabilities by Quarter

Acquisition Contingent Consideration Liabilities — Current fair value ($M) ($M)

Pfizer Acquisition Contingent Consideration Liabilities: $96M in Q2 2026.

Latest, Q2 2026
96
Period ended Jun 28, 2026
Change on a year earlier
–
History
13 quarters
Since Q4 2018
Sources
12
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-04) ↗

Milestone & royalty contingent obligations from Biohaven (Nurtec/Zavzpret), Metsera, and other business combinations.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAcquisition Contingent Consideration Liabilities — Current fair value ($M) ($M)Year on yearSource
Q2 2026Jun 28, 202696–Form 10-Q (filed 2026-08-04) ↗
Q1 2026Mar 29, 202695–Form 10-Q (filed 2026-05-05) ↗
Q4 2025Dec 31, 202595+143.6%Form 10-Q (filed 2026-08-04) ↗
Q4 2024Dec 31, 202439-78.2%Form 10-K (filed 2026-02-26) ↗
Q4 2023Dec 31, 2023179+326.2%Form 10-K (filed 2025-02-27) ↗
Q4 2022Dec 31, 202242-68.9%Form 10-K (filed 2024-02-22) ↗
Q4 2021Dec 31, 2021135+9.8%Form 10-K (filed 2023-02-23) ↗
Q4 2020Dec 31, 2020123-23.1%Form 10-K (filed 2022-02-24) ↗
Q3 2020Sep 27, 2020125–Form 10-Q (filed 2020-11-05) ↗
Q2 2020Jun 28, 2020157–Form 10-Q (filed 2020-08-06) ↗
Q1 2020Mar 29, 2020124–Form 10-Q (filed 2020-05-07) ↗
Q4 2019Dec 31, 2019160-42.9%Form 10-K (filed 2021-02-25) ↗
Q4 2018Dec 31, 2018280–Form 10-K (filed 2020-02-27) ↗

Breakdown

What makes up acquisition Contingent Consideration Liabilities

Cite this data

StockData. (2026). Pfizer Acquisition Contingent Consideration Liabilities ($M), quarterly Q4 2018–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/cc-liab-cur

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.